Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biovie Inc (BIVI)

Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,859
  • Shares Outstanding, K 39,925
  • Annual Sales, $ 0 K
  • Annual Income, $ -50,260 K
  • 60-Month Beta 0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.46
Trade BIVI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.17
  • Most Recent Earnings $-0.22 on 02/12/24
  • Latest Earnings Date 05/10/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 49.56% ( -26.80%)
  • Historical Volatility 45.58%
  • IV Percentile 4%
  • IV Rank 2.72%
  • IV High 1,006.04% on 04/17/24
  • IV Low 22.81% on 02/05/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 130
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 4,082
  • Open Int (30-Day) 6,619

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +232,425.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4521 +7.54%
on 04/17/24
0.5499 -11.58%
on 04/12/24
+0.0200 (+4.29%)
since 04/10/24
3-Month
0.4450 +9.26%
on 04/08/24
3.3100 -85.31%
on 03/01/24
-0.6838 (-58.44%)
since 02/09/24
52-Week
0.4450 +9.26%
on 04/08/24
8.1300 -94.02%
on 05/11/23
-7.5688 (-93.96%)
since 05/10/23

Most Recent Stories

More News
Why Shares of BioVie Jumped This Week

BioVie's announcement regarding a phase 2 trial for its lead therapy helped raise the stock's price.

BIVI : 0.4862 (-2.25%)
Why Shares of BioVie Jumped 51.7% in February

The company is forging ahead with a phase 3 trial for its lead therapy.

BIVI : 0.4862 (-2.25%)
Why Shares of BioVie Rose 15.3% in December

The biotech announced positive news from a pair of phase 2 clinical trials.

BIVI : 0.4862 (-2.25%)
Does BioVie Inc. (BIVI) Have the Potential to Rally 52% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 52.1% in BioVie Inc. (BIVI). While the effectiveness of this highly sought-after metric is questionable, the positive...

BIVI : 0.4862 (-2.25%)
Here's Why Momentum in BioVie Inc. (BIVI) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, BioVie Inc. (BIVI) could be a great choice. It is one of the several stocks that passed through our "Recent Price...

BIVI : 0.4862 (-2.25%)
Why BioVie Stock Is Soaring Today

The more investors learned about BioVie's latest clinical results, the more they liked.

BIVI : 0.4862 (-2.25%)
Why BioVie's Shares Tumbled Tuesday

The clinical-stage biotech released data on its prospective Alzheimer's therapy.

BIVI : 0.4862 (-2.25%)
Pre-Market Brief: Stocks Mixed As Resurgent Fed Fears Weigh On Sentiment, China Reopening Hopes

December S&P 500 futures (ESZ22) are trending up +0.08% this morning after three major US benchmark indices finished the regular session sharply lower as market participants fretted that stronger-than-anticipated...

ESZ22 : 3,871.47s (-0.66%)
TSLA : 168.47 (-2.04%)
GTLB : 52.87 (-0.08%)
BIVI : 0.4862 (-2.25%)
SUMO : 12.04 (-0.08%)
GIII : 27.99 (-0.85%)
AXON : 303.43 (-1.83%)
POWL : 168.23 (+1.74%)
Are Medical Stocks Lagging BioVie (BIVI) This Year?

Here is how BioVie Inc. (BIVI) and Immunovant, Inc. (IMVT) have performed compared to their sector so far this year.

BIVI : 0.4862 (-2.25%)
IMVT : 29.39 (-1.04%)
Here's What Could Help BioVie Inc. (BIVI) Maintain Its Recent Price Strength

BioVie Inc. (BIVI) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our...

BIVI : 0.4862 (-2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

See More

Key Turning Points

3rd Resistance Point 0.5108
2nd Resistance Point 0.5054
1st Resistance Point 0.4958
Last Price 0.4862
1st Support Level 0.4808
2nd Support Level 0.4754
3rd Support Level 0.4658

See More

52-Week High 8.1300
Fibonacci 61.8% 5.1943
Fibonacci 50% 4.2875
Fibonacci 38.2% 3.3807
Last Price 0.4862
52-Week Low 0.4450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar